Recent Publications

Dr. Barnes

Younossi ZM, McCullough AJ, Ong JP, Barnes DW, et al. Obesity and nonalcoholic fatty liver disease in chronic hepatitis C. J Clin Gastroenterol 2004;38:705-9.

Suman A, Barnes DS, Zein NN, Levinthal GN et al. Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child-Pugh and MELD scores. Clin Gastroenterol Hepatol 2004;2:719-23.

Younossi ZM, Mullen KD, Hodnick S, Barnes DS, Carey WD, et al. Triple combination of interferon alpha 2b, ribavirin, and amantadine for treatment of hepatitis c. J Clinical Gastro 2003; 36: 727-430.

Adhami T, Quinn MK, Barnes D, et al. Treatment of hepatitis C after orthotopic liver transplantation. Gastroenterology 2002; 123:81 (suppl).

Barnes DS. Gallbladder and biliary tract disease. July 9, 2002. Available at: www.clevelandclinicmeded.com/diseasemanagement.

Barnes DS. Intrahepatic cholestatic liver disease. July 9, 2002. Available at: www.clevelandclinicmeded.com/diseasemanagement.

Saadeh S, Mullen KD, Carey W, Barnes D, Baker M, Gramlich T, Vogt D. Infarcted giant liver hemangioma presenting with signs of acute inflammation. Practical Gastroenterology March 2003;68-72.

Vidigal P, Germer JJ, Zein NN. Polymorphisms in interleukin-10, tumor necrosis factor-? and transforming growth factor- 1 genes: Association with disease and treatment outcomes in hepatitis C infection. J Hepatology 2002:36:271-277.

Vogt DP, Henderson JM, Carey WD, Barnes DS. The long-term survival and causes of death in-patients who survive at least 1 year after liver transplantation. Surgery 2002;132:775-80.

Dr. Carey

Carey, WD Editor-In-Chief, Disease Management Project, (a 115 chapter text book of internal medicine on line (www.clevelandclinicmeded.com) Updated Quarterly.

Younossi ZM, Mullen KD, Hodnick S, Barnes DS, Carey WD, et al. Triple combination of interferon alpha 2b, ribavirin, and amantadine for treatment of hepatitis c. J Clinical Gastro 2003; 36: 727-430.

Saadeh S, Behrens PW, Parsi MA, Carey WD, Connor JT, Grealis M, Barnes DS. The utility of the 13-C-galactose breath test as a measure of liver function. Aliment Pharmacol Ther 2003; 18: 995-1002.

Carey, W.D. Navigating the Management of Hepatitis C. Cleveland Clinic Journal of Medicine 2003; 70: S1-S70.

Carey, W.D. Tests and screening strategies for the diagnosis of hepatitis C. Cleveland Clinic Journal of Medicine 2003; 70: 7S-13S.

Chu C-J, Keeffe EB, Han S-H, Perrillo R.P, Min AD, Soldevila-Pico C, Carey W, Brown RS, Luketic VA, Terrault N, Lok A. Prevalence of HBV precore/core promoter variants in the United States. Hepatology 2003; 38: 619 – 628.

Chu C-J, Keefe EB, Han S-H, Perrillo RP, Min AD, Soldevila-Pico C, Carey W, et al. Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology 2003; 125: 444- 451.

Fontana RJ, Keefe EB, Carey WD, Fried M, Reddy R, Kowdley KV, Soldevila-Pico C, McClure LA, Lok A S.F. Effect of lamivudine on survival of 309 north american patients awaiting liver transplantation for chronic hepatitis b. Liver Transplantation 2002; 8: 433 - 439.

Gordon SM, Carey WD, Yen- Lieberman B, et al. A fatal case of hepatitis C seroconversion following living- related kidney transplantation: another argument for nucleic acid amplification testing of transplant recipients and donors. Transplantation Infectious Disease 2002; 4:113 - 114 (letter).

Saadeh S, Mullen KD, Carey W, Barnes D, Baker M, Gramlich T, Vogt D. Infarcted giant liver hemangioma presenting with signs of acute inflammation. Practical Gastroenterology March 2003;68-72.

Vidigal P, Germer JJ, Zein NN. Polymorphisms in interleukin-10, tumor necrosis factor-? and transforming growth factor- 1 genes: Association with disease and treatment outcomes in hepatitis C infection. J Hepatology 2002:36:271-277.

Vogt DP, Henderson JM, Carey WD, Barnes DS. The long-term survival and causes of death in-patients who survive at least 1 year after liver transplantation. Surgery 2002;132:775-80.

Dr. Chawla

Chawla, A. Lichtenstein GR. Clinical complications of IBD therapy, in press.

Chawla, A., Judge TA, Lichtenstein, GR. Evaluation of polypoid lesions in inflammatory bowel disease. Gastrointest Endosc Clin N Am. 2002;12(3):525-34, ix.

Dr. O'Shea

O’Shea RS. Transplantation 2003. in Zein NN, ed. Year Book in Gastroenterology and Hepatology 2004. Clinical Publishing Services. Oxford. December, 2004.

O’Shea RS. Hepatitis in Women’s Health Encyclopedia. Ed. Loue S, Sajatovic M. Kluwer Academic/Plenum Publishing. July 2004.

Dr. Remzi

Berber E, Senagore AJ, Remzi FH, Rogers S, Herceg N, Casto K, Siperstein A. Laparoscopic radiofrequency ablation of liver tumors combined with colorectal procedures. Surgical Laparosc. Endosc. Percutan Tech., 2004 Aug.; 14 (4): 186-90.

Dr. Siperstein

Berber E, Senagore AJ, Remzi FH, Rogers S, Herceg N, Casto K, Siperstein A. Laparoscopic radiofrequency ablation of liver tumors combined with colorectal procedures. Surgical Laparosc. Endosc. Percutan Tech., 2004 Aug.; 14 (4): 186-90.

Dr. Wakim-Fleming

Wakim-Fleming J, Zein NN. Liver diseases in pregnancy. American College of Gastroenterology Topic Review and Practice Guidelines 2004;2:719-723.

Dr. Zein

Zein NN, Germer JJ, Vidigal P. Racial differences in polymorphisms of interleukin-10, tumor necrosis factor-a, and transforming growth factor-ß1 genes in patients with chronic liver disease. Am J Trop Med Hyg 2004;70:434-437.

Zein NN, Chronic viral hepatitis B and C infections in The Year in Gastroenterology and Hepatology. Clinical Publishing, Oxford, England 2004.

Metwally MA, Zein CO, Zein NN. Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection. Am J Gastroenterol 2004;99:286-291.

Suman A, Barnes DS, Zein NN, Levinthal GN et al. Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child-Pugh and MELD scores. Clin Gastroenterol Hepatol 2004;2:719-23.

Parsi M, Aterja A, Zein NN. Spontaneous bacterial peritonitis: Recent data on incidence and diagnosis. Clev Clin J Med 2004;71:569-576.

Wakim-Fleming J, Zein NN. Liver diseases in pregnancy. American College of Gastroenterology Topic Review and Practice Guidelines 2004;2:719-723.

Abdelmalek MF, Pasha TM, Zein NN, Douglas DD. Subclinical reactivation of hepatitis C virus in liver transplant recipients with past exposure. Liver Transplant 2003;9:1253-1257.

Zein NN. Epidemiology and natural history of hepatitis C Infection. Clev Clin J Med 2003;70:2-6.

Metwally M, Zein CO, Zein NN. Regression of fibrosis and cirrhosis in chronic HCV patients treated with interferon-based therapies. Gastroenterology 2003;124:1561.

Wakim-Fleming J, Zein NN. Liver diseases in pregnancy. American College of Gastroenterology Practice Guidelines 2003 (online publication).

Cohen A, Stegall MD, Wiesner RH, Zein NN: Significance of renal dysfunction in liver transplant recipients Liver Transplantation 2002;8:916-921. Senior Author.

Germer JJ, Zein NN, Smith TF, Harmsen WS, Hoskin TL, Patel R. Comparison of detection of hepatitis C virus (HCV) by transcription-mediated amplification (TMA) versus COBAS AMPLICOR™ HCV test, version 2.0 (AMPLICOR) in patients undergoing antiviral therapy (J Clin Micro).

Ten RM, Anderson PM, Zein NN, Temesgen Z, Clawson ML, Weiss, W. Interleukin-2 liposomes for primary immune deficiency: low toxicity using aerosol route. Int J Immunopharmacology 2002;2:333-344.

Vidigal P, Germer JJ, Zein NN. Polymorphisms in interleukin-10, tumor necrosis factor-? and transforming growth factor-1 genes: Association with disease and treatment outcomes in hepatitis C infection. J Hepatology 2002:36:271-277.

Zein CO, Zein NN. Advances in Therapy for Patients with Acute or Chronic Hepatitis C. Microbes and Infections 2002;4: 1237-1246.